ERGO sells stake in Jenoptik

(PresseBox) ( Jena, )
- Around 4.88 million shares with a value of over 60 million euros placed
- Strong demand from institutional investors in Germany and abroad
- Shareholder base widened: free float of the technology group at 75 percent

The longstanding major shareholder of JENOPTIK AG, ERGO Versicherungsgruppe, has sold its approximately 8.5 percent stake in Jenoptik to institutional investors in Germany and abroad. Due to strong demand, the total of around 4.88 million shares in JENOPTIK AG were swiftly and fully placed on the evening of April 2, 2014 at a price of 12.15 euros per share by means of an accelerated book building process. The sole bookrunner was UBS.

ERGO Versicherungsgruppe, which had held a stake in the company for over ten years, holds no Jenoptik shares following the sale. "The very good work of the management had a positive effect on the share price development which we used for an exit. We are convinced that JENOPTIK AG will continue to succeed in the market with its business model," says Dr. Daniel von Borries, member of the Board of Management of ERGO and responsible for investments. ECE Industriebeteiligungen mbH and Thüringer Industriebeteiligungs GmbH & Co. KG remain the largest shareholders with stakes of 14.01 percent and 11.0 percent respectively.

"This successful and above all rapid placement showed us that investors are impressed by our economic strength, our medium-term objectives and our sustainable strategy. It demonstrates institutional investors' confidence in Jenoptik. The widening of the shareholder base also gives us the opportunity to improve the tradability of the share and thus further improve its perception on the capital market," says Rüdiger Andreas Günther, Chief Financial Officer of JENOPTIK AG.
The publisher indicated in each case is solely responsible for the press releases above, the event or job offer displayed, and the image and sound material used (see company info when clicking on image/message title or company info right column). As a rule, the publisher is also the author of the press releases and the attached image, sound and information material.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to